Running marathons or endurance races is often seen as a hallmark of peak fitness. However, a groundbreaking new study led by Inova oncologist Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising prevalence of precancerous colon growths among extreme runners. Recently featured in The New York Times, the study opens new discussions about screening opportunities.
Article links:
Inova Schar Cancer was among the trial’s leading-enrolling sites, with participation led by principal investigator…
Leesburg, VA – Inova Loudoun Hospital Mobile Health Services will be providing countywide blood pressure…
Also recognized for 9 “Exemplars” for top performance Leaders and team members celebrate Inova Mount…
New Prince William County location offers medical oncology, hematology, breast surgery, infusion and Inova Peterson…
Kathleen Harden, MD is a breast oncology physician, board-certified in medical oncology and internal medicine…
Dru Smith, an interstitial lung disease patient, shares his experience and care journey. Reston resident…